Plasma Concentration of Somatostatin and Endocannabinoids After GA and RA in Upper Extremity Trauma Surgery
SECsGRUES
Comparative Measurement of the Concentration of Blood Somatostatin and Fatty Amid Acids in Upper Extremity Trauma Surgery Under General and Regional Anesthesia
1 other identifier
interventional
100
1 country
1
Brief Summary
The application of RA can decrease the central sensitization and chronic pain after trauma surgery. The plasma concentrations of somatostatin and fatty acid amides were not studied up to this time in this kind of settings, so investigators believe that this is the first work that shows how upper extremity nerve blockade changes the plasma concentration of somatostatin and fatty acid amides in upper limb surgery in trauma patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable postoperative-pain
Started Nov 2019
Longer than P75 for not_applicable postoperative-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 5, 2019
CompletedFirst Posted
Study publicly available on registry
August 1, 2019
CompletedStudy Start
First participant enrolled
November 5, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 20, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 10, 2022
CompletedNovember 5, 2021
November 1, 2021
2 years
June 5, 2019
November 4, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Somatostatin concentration in plasma
Plasma concentrations of somatostatin straight after and 6 hours after surgery.
0-6 hours after surgery
Secondary Outcomes (2)
Endocannabinoid concentrations in plasma
0-6 hours
Corticosteroid concentrations in plasma
0-6 hours
Other Outcomes (1)
Postoperative pain intensity: verbal numeric rate scale
0-24 hours
Study Arms (2)
Upper extremity surgery under general anaesthesia
ACTIVE COMPARATORFentanyl 2 mcg/kg iv, propofol 2 mg/kg iv induction, 1MAC sevoflurane maintenance
Upper extremity surgery under regional anaesthesia
ACTIVE COMPARATORBupivacaine brachial plexus block 0.4 ml/kg of 0.33% solution
Interventions
Forearm, wrist and hand surgery after fentanyl and propofol induction of anaesthesia, with sevoflurane maintenance
Forearm, wrist and hand surgery under brachial plexus block with 0.4 ml/kg of 0.33% bupivacaine solution Other Names: Marcaine 5 mg/ml Astra Zeneca OGYI-T 6496/14
Eligibility Criteria
You may qualify if:
- upper extremity fracture
- surgery of hand/forearm or upper arm
- unpremedicated patients
- scheduled for elective or emergency trauma
You may not qualify if:
- psycho-mental conditions interfering with consent or assessment
- the patient refused to participate
- preexisting chronic pain condition
- daily analgesic or sedative or steroid consumption
- sedative or analgesic premedication
- pre-existing neuro-endocrine disorders
- antecedent cancer
- advanced liver or kidney disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Pécs, Medical School
Pécs, Baranya, 7632, Hungary
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Robert G Almasi, PhD.Habil.
University of Pecs, Medical School, Clinical Centre, Pain Medicine Dept.of Anesth Int Care
- PRINCIPAL INVESTIGATOR
Zsofia Kriszta, MD.
University of Pecs, Medical School, Clinical Centre, Dept.of Anesth Int Care
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The labour analyst, the investigator, the statistician is unaware of group allocation.
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 5, 2019
First Posted
August 1, 2019
Study Start
November 5, 2019
Primary Completion
November 20, 2021
Study Completion
January 10, 2022
Last Updated
November 5, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share